BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

US Patent Innovations, LLC Completes Plasma Technology Research Agreement With the George Washington University


2/15/2013 9:19:34 AM

TAKOMA PARK, Md.--(BUSINESS WIRE)--US Patent Innovations, LLC (USPI), a private biomedical devices company, announced today that it signed a five-year research agreement with The George Washington University of Washington, D.C. (GWU) on February 6, 2013. Under the agreement, USPI will provide funding for collaborative research exploring the mechanisms of plasma cutting and coagulation of biological tissue, with the goal of developing a set of devices utilizing both Cold and Hybrid Plasma applications in surgery. The research project will be led by principal investigator Dr. Michael Keidar of GWU's Mechanical and Aerospace Engineering Department, and co-investigator Jerome Canady, M.D., Director of Research at Plasma Medicine Life Science, LLC, a new subsidiary of USPI.

The new plasma devices will complement the Canady Plasma® and Canady Vieira Hybrid PlasmaTM lines of products already in distribution by USPI's subsidiary, US Medical Innovations, LLC (USMI) and by WEM Equipamentos Electronicos LTDA (Ribeirao Preto - Sao Paulo, Brazil). These devices utilize a breakthrough approach to electrosurgery, known as "Hybrid Plasma Technology," permitting surgery with virtually no blood loss and without the use of a traditional scalpel blade.

Commenting on the agreement, Dr. Canady said, "This exciting development enhances our recent Technology Transfer Agreement with GWU and Johns Hopkins University. The resulting research surrounding Cold Plasma devices for the selective eradication of cancer cells, together with our Hybrid Plasma Technology development efforts with WEM, will provide a platform for new product development that will impact the manner in which surgery as well as cancer treatments are performed in the future."

Contacts

US Medical Innovations, LLC

Alicia Woodley, Esq.

Vice President of Marketing, Mergers & Acquisitions, Associate Counsel

6930 Carroll Ave., Ste 1000 Takoma Park, MD 20912 301-270-0147 Fax: 301-270-0849 info@usmedinnov.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->